Clinical Trial Update: CorVad Myocardial Infarction Complicated with Cardiogenic Shock Trial [NA]

View source ↗

Summary

A clinical trial update for CorVad evaluating myocardial infarction complicated by cardiogenic shock. The study is currently not yet recruiting and is sponsored…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiogenic Shock

Drugs mentioned

• CorVad

Snippet

Sponsor: Shenzhen Core Medical Technology CO.,LTD. | Conditions: Cardiogenic Shock | NA | Status: NOT_YET_RECRUITING